Vectura signs US drug deal for GyroHaler
This article was originally published in Clinica
Executive Summary
Vectura, the Chippenham, UK pulmonary drug delivery specialist, has signed a deal with a "leading international pharmaceutical company" to develop a drug-device product for the US respiratory market.